Table 1.
Descriptive data of children included in the study
| Lactobacillus reuteri % (n/N) | Placebo % (n/N) | p-value* | |
|---|---|---|---|
| Boys |
55 (16/29) |
50 (16/32) |
0.82 |
| First born |
55 (16/29) |
63 (20/32) |
0.77 |
| Caesarean delivery |
14 (4/29) |
3 (1/32) |
0.16 |
| Birth weight (g) (mean ± SE) |
3656 ± 434 |
3469 ± 429 |
0.10* |
| Birth length (cm) |
51.3 ± 2.0 |
50.6 ± 1.9 |
0.18* |
| Parental smoking |
10 (3/29) |
9 (3/32) |
0.91 |
| Furry pets |
7 (2/29) |
13 (4/32) |
0.51 |
| Maternal atopy |
79 (23/29) |
75 (24/32) |
0.89 |
| Paternal atopy |
62 (18/29) |
69 (22/32) |
0.80 |
| Breastfeeding |
|
|
|
| 3 months, exclusive |
59 (17/29) |
78 (23/32) |
0.62 |
| 6 months, partial |
83 (24/29) |
78 (24/32) |
0.80 |
| Antibiotics |
|
|
|
| 0–12 months |
34 (10/29) |
16 (5/32) |
0.18 |
| 12–24 months |
48 (14/29) |
53 (17/32) |
0.83 |
| Day-care |
|
|
|
| 0–12 months |
0 (0/29) |
3 (1/32) |
0.35 |
| 12–24 months |
86 (25/29) |
94 (30/32) |
0.82 |
| Recurrent wheeze |
3 (1/29) |
6 (2/32) |
0.63 |
| Eczema |
28 (8/29) |
28 (9/32) |
0.97 |
| Allergic disease |
34 (10/29) |
38 (12/32) |
0.87 |
| Sensitisation |
38 (11/29) |
34 (11/32) |
0.84 |
| IgE-assoc. Disease |
10 (3/29) |
16 (5/32) |
0.59 |
| SPT (12 m cumulative) |
10 (3/29) |
16 (5/32) |
0.37 |
| SPT (24 m cumulative) |
17 (5/29) |
16 (5/32) |
0.89 |
| Egg |
10 (3/29) |
13 (4/32) |
0.81 |
| Milk |
3 (1/29) |
0 (0/32) |
0.30 |
| Cat |
3 (1/29) |
6 (2/32) |
0.63 |
| Birch |
3 (1/29) |
3 (1/32) |
0.95 |
| Spec IgE (kU/L) |
34 (10/29) |
31 (10/32) |
0.85 |
| Ovalbumin |
7 (2/29) |
22 (7/32) |
0.15 |
| b-lactoglobulin |
24 (7/29) |
9 (3/32) |
0.19 |
| fx5 | 31 (9/29) | 28 (9/32) | 0.85 |
X 2 test. *t-test.